Literature DB >> 11139404

Identification of Cys140 in helix 4 as an exofacial cysteine residue within the substrate-translocation channel of rat equilibrative nitrobenzylthioinosine (NBMPR)-insensitive nucleoside transporter rENT2.

S Y Yao1, M Sundaram, E G Chomey, C E Cass, S A Baldwin, J D Young.   

Abstract

The human and rat equilibrative nucleoside transporter proteins hENT1, rENT1, hENT2 and rENT2 belong to a family of integral membrane proteins with 11 potential transmembrane segments (TMs), and are distinguished functionally by differences in transport of nucleobases and sensitivity to inhibition by nitrobenzylthioinosine (NBMPR) and vasoactive drugs. In the present study, we have produced recombinant hENT1, rENT1, hENT2 and rENT2 in Xenopus oocytes and investigated uridine transport following exposure to the impermeant thiol-reactive reagent p-chloromercuriphenyl sulphonate (PCMBS). PCMBS caused reversible inhibition of uridine influx by rENT2, but had no effect on hENT1, hENT2 or rENT1. This difference correlated with the presence in rENT2 of a unique Cys residue (Cys(140)) in the outer half of TM4 that was absent from the other ENTs. Mutation of Cys(140) to Ser produced a functional protein (rENT2/C140S) that was insensitive to inhibition by PCMBS, identifying Cys(140) as the exofacial Cys residue in rENT2 responsible for PCMBS inhibition. Uridine protected wild-type rENT2 against PCMBS inhibition, suggesting that Cys(140) in TM4 lies within or is closely adjacent to the substrate-translocation channel of the transporter. TM4 has been shown previously to be within a structural domain (TMs 3-6) responsible for interactions with NBMPR, vasoactive drugs and nucleobases.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11139404      PMCID: PMC1221582          DOI: 10.1042/0264-6021:3530387

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  26 in total

Review 1.  Adenosine and adenosine receptors in the cardiovascular system: biochemistry, physiology, and pharmacology.

Authors:  J C Shryock; L Belardinelli
Journal:  Am J Cardiol       Date:  1997-06-19       Impact factor: 2.778

2.  Molecular cloning, functional expression and chromosomal localization of a cDNA encoding a human Na+/nucleoside cotransporter (hCNT2) selective for purine nucleosides and uridine.

Authors:  M W Ritzel; S Y Yao; A M Ng; J R Mackey; C E Cass; J D Young
Journal:  Mol Membr Biol       Date:  1998 Oct-Dec       Impact factor: 2.857

3.  Functional production and reconstitution of the human equilibrative nucleoside transporter (hENT1) in Saccharomyces cerevisiae. Interaction of inhibitors of nucleoside transport with recombinant hENT1 and a glycosylation-defective derivative (hENT1/N48Q).

Authors:  M F Vickers; R S Mani; M Sundaram; D L Hogue; J D Young; S A Baldwin; C E Cass
Journal:  Biochem J       Date:  1999-04-01       Impact factor: 3.857

Review 4.  Nucleoside transporters: molecular biology and implications for therapeutic development.

Authors:  S A Baldwin; J R Mackey; C E Cass; J D Young
Journal:  Mol Med Today       Date:  1999-05

5.  Chimeric constructs between human and rat equilibrative nucleoside transporters (hENT1 and rENT1) reveal hENT1 structural domains interacting with coronary vasoactive drugs.

Authors:  M Sundaram; S Y Yao; A M Ng; M Griffiths; C E Cass; S A Baldwin; J D Young
Journal:  J Biol Chem       Date:  1998-08-21       Impact factor: 5.157

6.  Nitrobenzylthioinosine-sensitive nucleoside transport system: mechanism of inhibition by dipyridamole.

Authors:  S M Jarvis
Journal:  Mol Pharmacol       Date:  1986-12       Impact factor: 4.436

7.  Enzymic cleavage as a probe of the molecular structures of mammalian equilibrative nucleoside transporters.

Authors:  F Y Kwong; J S Wu; M M Shi; H E Fincham; A Davies; P J Henderson; S A Baldwin; J D Young
Journal:  J Biol Chem       Date:  1993-10-15       Impact factor: 5.157

8.  Erythrocyte nucleoside transport: asymmetrical binding of nitrobenzylthioinosine to nucleoside permeation sites.

Authors:  S M Jarvis; D McBride; J D Young
Journal:  J Physiol       Date:  1982-03       Impact factor: 5.182

9.  Mammalian nitrobenzylthioinosine-sensitive nucleoside transport proteins. Immunological evidence that transporters differing in size and inhibitor specificity share sequence homology.

Authors:  F Y Kwong; H E Fincham; A Davies; N Beaumont; P J Henderson; J D Young; S A Baldwin
Journal:  J Biol Chem       Date:  1992-10-25       Impact factor: 5.157

10.  Evidence for the asymmetrical binding of p-chloromercuriphenyl sulphonate to the human erythrocyte nucleoside transporter.

Authors:  C M Tse; J S Wu; J D Young
Journal:  Biochim Biophys Acta       Date:  1985-09-10
View more
  17 in total

1.  Point mutations in a nucleoside transporter gene from Leishmania donovani confer drug resistance and alter substrate selectivity.

Authors:  G Vasudevan; B Ullman; S M Landfear
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-15       Impact factor: 11.205

Review 2.  Nucleoside and nucleobase transporters in parasitic protozoa.

Authors:  Scott M Landfear; Buddy Ullman; Nicola S Carter; Marco A Sanchez
Journal:  Eukaryot Cell       Date:  2004-04

3.  Transmembrane segment 11 appears to line the purine permeation pathway of the Plasmodium falciparum equilibrative nucleoside transporter 1 (PfENT1).

Authors:  Paul M Riegelhaupt; I J Frame; Myles H Akabas
Journal:  J Biol Chem       Date:  2010-03-24       Impact factor: 5.157

4.  An ab Initio structural model of a nucleoside permease predicts functionally important residues.

Authors:  Raquel Valdés; Shirin Arastu-Kapur; Scott M Landfear; Ujwal Shinde
Journal:  J Biol Chem       Date:  2009-05-08       Impact factor: 5.157

5.  Substituted cysteine accessibility method analysis of human concentrative nucleoside transporter hCNT3 reveals a novel discontinuous region of functional importance within the CNT family motif (G/A)XKX3NEFVA(Y/M/F).

Authors:  Melissa D Slugoski; Amy M L Ng; Sylvia Y M Yao; Colin C Lin; Ras Mulinta; Carol E Cass; Stephen A Baldwin; James D Young
Journal:  J Biol Chem       Date:  2009-04-20       Impact factor: 5.157

Review 6.  Equilibrative nucleoside transporters-A review.

Authors:  Rebba C Boswell-Casteel; Franklin A Hays
Journal:  Nucleosides Nucleotides Nucleic Acids       Date:  2016-10-19       Impact factor: 1.381

7.  Cysteine-accessibility analysis of transmembrane domains 11-13 of human concentrative nucleoside transporter 3.

Authors:  Jing Zhang; Tracey Tackaberry; Mabel W L Ritzel; Taylor Raborn; Gerry Barron; Stephen A Baldwin; James D Young; Carol E Cass
Journal:  Biochem J       Date:  2006-03-01       Impact factor: 3.857

8.  Nucleobase transport by human equilibrative nucleoside transporter 1 (hENT1).

Authors:  Sylvia Y M Yao; Amy M L Ng; Carol E Cass; Stephen A Baldwin; James D Young
Journal:  J Biol Chem       Date:  2011-07-27       Impact factor: 5.157

Review 9.  The equilibrative nucleoside transporter family, SLC29.

Authors:  Stephen A Baldwin; Paul R Beal; Sylvia Y M Yao; Anne E King; Carol E Cass; James D Young
Journal:  Pflugers Arch       Date:  2003-06-28       Impact factor: 3.657

10.  Cysteine cross-linking defines the extracellular gate for the Leishmania donovani nucleoside transporter 1.1 (LdNT1.1).

Authors:  Raquel Valdés; Ujwal Shinde; Scott M Landfear
Journal:  J Biol Chem       Date:  2012-11-13       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.